Perspective Therapeutics (CATX) Retained Earnings (2011 - 2026)
Perspective Therapeutics (CATX) posted Retained Earnings of -$361.0 million for Q1 2026, down 328308.18% sequentially from $110000.0 in Q4 2025, and down 1900252.63% YoY from N/an in Q1 2025.
Perspective Therapeutics (CATX) Retained Earnings (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Retained Earnings for 16 years, with the latest figure at -$361.0 million in Q1 2026.
- Quarterly Retained Earnings fell 1900252.63% year-over-year to -$361.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$361.0 million (down 1900252.63% YoY) and the FY2025 annual result came in at $110000.0, up 100.05% from the prior year.
- Retained Earnings declined to -$361.0 million in Q1 2026 per CATX's latest filing, from $110000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $110000.0 in Q4 2025 and troughed at -$361.0 million in Q1 2026.
- A 5-year average of -$153.0 million and a median of -$127.8 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings surged 100.05% in 2025, then plunged 1900252.63% in 2026.
- Over 5 years, Retained Earnings stood at -$105.9 million in 2022, then slumped by 43.9% to -$152.4 million in 2023, then sank by 52.01% to -$231.7 million in 2024, then surged by 100.05% to $110000.0 in 2025, then sank by 328308.18% to -$361.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$361.0 million, $110000.0, and -$297.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - | -387.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -387.82 Mn |
| Mar 31, 2026 | -361.03 Mn |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | -297.40 Mn |
| Jun 30, 2025 | -271.38 Mn |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | -231.72 Mn |
| Sep 30, 2024 | -191.55 Mn |
| Jun 30, 2024 | -176.43 Mn |
| Mar 31, 2024 | -164.72 Mn |
| Dec 31, 2023 | -152.44 Mn |
| Sep 30, 2023 | -127.77 Mn |
| Jun 30, 2023 | -117.41 Mn |
| Mar 31, 2023 | -106.30 Mn |
| Dec 31, 2022 | -105.93 Mn |
| Sep 30, 2022 | -102.67 Mn |
| Jun 30, 2022 | -98.60 Mn |
| Mar 31, 2022 | -96.52 Mn |
| Dec 31, 2021 | -95.17 Mn |
| Sep 30, 2021 | -93.57 Mn |